Panel Discussion 3: Build a Successful MedTech Venture

Mr. Yi Yang is a seasoned medical technology executive, entrepreneur, and pioneer with over 30 years of experience driving disruptive innovations from concept to global commercial scale. Based in Silicon Valley, he has consistently bridged the gap between cutting-edge engineering and impactful clinical execution, ultimately improving the lives of tens of thousands of patients worldwide.

Currently, he serves as the Founder and Managing Director of IC2R, a premier MedTech innovation venture foundry designed to accelerate the development of next-generation medical solutions.  He is also the Chief Technology Officer of Incept, a highly prolific MedTech incubator and accelerator renowned for shaping the future of healthcare.

Prior to these roles, he was the Co-founder and former Chief Technology Officer of Imperative Care—the 21st company accelerated by Incept. During his tenure, he played a pivotal role in the company's meteoric growth, raising over $500 million in capital, securing key issued patents, and overseeing R&D, manufacturing operations, and a rapid commercial ramp that took the company from zero to a $40 million run-rate revenue. To date, the technologies developed under his leadership have successfully treated more than 80,000 ischemic stroke patients.

Mr. Yang’s extensive leadership history includes serving as Co-founder and VP of R&D at CAVU Medical, Inc., an obesity-focused startup where he was instrumental in securing seed and Series A funding. He also served as VP of R&D at Boston Scientific Corporation. He joined Boston Scientific through its $200 million acquisition of EndoTex Interventional Systems, Inc., where he was VP of R&D. Earlier in his career, he was a technical project manager at EP Technologies, Inc., which was also acquired by Boston Scientific for $150 million.

He holds a Bachelor of Science in Mechanical Engineering from the University of California, Berkeley, and a Master of Science in Mechanical Engineering from Stanford University. As a visionary builder and strategist at the intersection of engineering and life sciences, he continues to champion the advancement of the global MedTech ecosystem.